Prem Watsa’s Celgene Corp CELG Stock Holding History

Prem Watsa’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,500	Closed	-$1.37M	–	37
2019 Q1	$1.37M	Buy	+14,500	New	+$1.27M	0.06%	23

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Prem Watsa's CELG Position: Q2 2019 in Review

Prem Watsa sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 14,500 shares — an estimated $1.37M sold.

Prem Watsa first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $1.37M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Prem Watsa reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Prem Watsa sold 14,500 Celgene Corp shares in Q2 2019, an estimated $1.37M.
Prem Watsa first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
Prem Watsa's Celgene Corp position peaked at $1.37M in Q1 2019.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Fairfax Financial Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.